Bicycle Therapeutics plc

BCYC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$59-$79-$61-$52
Dep. & Amort.$2$2$2$2
Deferred Tax-$0-$0-$1-$1
Stock-Based Comp.$9$9$10$10
Change in WC-$23-$5-$36$36
Other Non-Cash$0$0$0-$4
Operating Cash Flow-$71-$73-$87-$9
Investing Activities
PP&E Inv.-$1-$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$0-$1-$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$0-$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0$2
Financing Cash Flow-$0-$0-$0$0
Forex Effect-$1$2$1-$2
Net Chg. in Cash-$73-$72-$87-$11
Supplemental Information
Beg. Cash$722$794$880$891
End Cash$649$722$793$880
Free Cash Flow-$72-$73-$87-$10
Bicycle Therapeutics plc (BCYC) Financial Statements & Key Stats | AlphaPilot